Φορτώνει......
Informing patients about their mutation tests: CDKN2A c.256G>A in melanoma as an example
BACKGROUND: When germline mutations are suspected as causal in cancer, patient DNA may be sequenced to detect variants in relevant genes. If a particular mutation has not been reported in reliable family studies, genetic counselors are facing a dilemma of appropriately informing patients. Many seque...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Hered Cancer Clin Pract |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7393828/ https://ncbi.nlm.nih.gov/pubmed/32760473 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13053-020-00146-x |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|